FIBRICOR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fibricor, and what generic alternatives are available?
Fibricor is a drug marketed by Athena and is included in one NDA. There are four patents protecting this drug.
The generic ingredient in FIBRICOR is fenofibric acid. There are four drug master file entries for this compound. Additional details are available on the fenofibric acid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fibricor
A generic version of FIBRICOR was approved as fenofibric acid by CHARTWELL RX on December 4th, 2013.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FIBRICOR?
- What are the global sales for FIBRICOR?
- What is Average Wholesale Price for FIBRICOR?
Summary for FIBRICOR
| US Patents: | 4 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 180 |
| Clinical Trials: | 2 |
| Drug Prices: | Drug price information for FIBRICOR |
| What excipients (inactive ingredients) are in FIBRICOR? | FIBRICOR excipients list |
| DailyMed Link: | FIBRICOR at DailyMed |
Recent Clinical Trials for FIBRICOR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mutual Pharmaceutical Company, Inc. | Phase 1 |
US Patents and Regulatory Information for FIBRICOR
FIBRICOR is protected by seven US patents.
Patents protecting FIBRICOR
Methods of use of fenofibric acid
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH HYPERLIPIDEMIAS
Methods of use of fenofibric acid
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ADJUNCTIVE THERAPY TO DIET TO PATIENTS WITH HYPERTRIGLYCERIDEMIA
Methods of use of fenofibric acid
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH MIXED DYSLIPIDEMIA
Methods of use of fenofibric acid
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH ELEVATED CHOLESTEROL AND/OR LIPID LEVELS
Methods of use of fenofibric acid
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH MIXED DYSLIPIDEMIA
Methods of use of fenofibric acid
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ADJUNCTIVE THERAPY TO DIET TO PATIENTS WITH HYPERTRIGLYCERIDEMIA
Methods of use of fenofibric acid
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH HYPERLIPIDEMIAS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Athena | FIBRICOR | fenofibric acid | TABLET;ORAL | 022418-001 | Aug 14, 2009 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Athena | FIBRICOR | fenofibric acid | TABLET;ORAL | 022418-002 | Aug 14, 2009 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Athena | FIBRICOR | fenofibric acid | TABLET;ORAL | 022418-001 | Aug 14, 2009 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Athena | FIBRICOR | fenofibric acid | TABLET;ORAL | 022418-001 | Aug 14, 2009 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Athena | FIBRICOR | fenofibric acid | TABLET;ORAL | 022418-001 | Aug 14, 2009 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Athena | FIBRICOR | fenofibric acid | TABLET;ORAL | 022418-002 | Aug 14, 2009 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Athena | FIBRICOR | fenofibric acid | TABLET;ORAL | 022418-002 | Aug 14, 2009 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
